Recombinant Human JAM-B/VE-JAM Protein

连接附着分子2(JAM2)重组蛋白 | 连接附着分子2(JAM2)重组蛋白

JAM-2 | JAM-B | Junctional adhesion molecule 2 | Vascular endothelial junction-associated molecule | VE-JAM | C21orf43 | CD322 antigen | CD322 | JAM2 | JAMB | JAM-B | JAM-BJAM-IT/VE-JAM | junctional adhesion molecule 2JAM-2 | junctional adhesion molecule

rp147908-10μg

10μg

无动物源

≥95%(SDS-PAGE)

Function May play a role in the processes of lymphocyte homing to secondary lymphoid organs.

Measured by the ability of the immobilized protein to support the adhesion of Jurkat human acute T cell leukemia cells. When cells (8 x 10^4 cells/well) are added to human JAM2-His coated plates (5 μg/mL, 100 μL/well), >30% will adhere after 60 minutes at 37℃.

重组表达

24 kDa

C-His

32 - 38 kDa, under reducing conditions; 32 - 38 kDa, under non-reducing conditions.

HEK293 Accession #: P57087 | HEK293

<0.1 EU/μg

人(Human)

29-236 aa

FSAPKDQQVVTAVEYQEAILACKTPKKTVSSRLEWKKLGRSVSFVYYQQTLQGDFKNRAEMIDFNIRIKNVTRSDAGKYRCEVSAPSEQGQNLEEDTVTLEVLVAPAVPSCEVPSSALSGTVVELRCQDKEGNPAPEYTWFKDGIRLLENPRLGSQSTNSSYTMNTKTGTLQFNTVSKLDTGEYSCEARNSVGYRRCPGKRMQVDDLNHHHHHH

Yes

Yes